Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 5 Apr 24 424B4 Prospectus supplement with pricing info
- 5 Apr 24 EFFECT Notice of effectiveness
-
1 Apr 24 S-1/A IPO registration (amended)
- 15 Mar 24 S-1 IPO registration
CTNM similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated February 15, 2024 (except for the last paragraph of Note 2, as to which the date is April 1, 2024), in the Registration Statement (Form S-1 No. 333-278003) and related Prospectus of Contineum Therapeutics, Inc. for the registration of 8,800,000 shares of its common stock.
/s/ Ernst & Young LLP |
San Diego, California |
April 1, 2024 |